|
|
Volumn 83, Issue 2, 1999, Pages 393-414
|
|
Management of early Parkinson's disease
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA TOCOPHEROL;
BROMOCRIPTINE;
CABERGOLINE;
CARBIDOPA PLUS LEVODOPA;
CATECHOL METHYLTRANSFERASE INHIBITOR;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
CLOZAPINE;
DECARBOXYLASE INHIBITOR;
DESMETHYLSELEGILINE;
LEVODOPA;
NEUROPROTECTIVE AGENT;
PERGOLIDE;
PLACEBO;
PRAMIPEXOLE;
ROPINIROLE;
SELEGILINE;
UNCLASSIFIED DRUG;
DEMENTIA;
DISEASE COURSE;
DOPAMINE METABOLISM;
DRUG EFFECT;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG POTENTIATION;
DYSKINESIA;
HUMAN;
INTRANASAL DRUG ADMINISTRATION;
MOTOR DYSFUNCTION;
NAUSEA;
NERVE CELL DEGENERATION;
NEUROPROTECTION;
NEUROTOXICITY;
ORAL DRUG ADMINISTRATION;
PARKINSON DISEASE;
PRIORITY JOURNAL;
REVIEW;
SUBLINGUAL DRUG ADMINISTRATION;
TRANSDERMAL DRUG ADMINISTRATION;
TREATMENT OUTCOME;
TREATMENT PLANNING;
|
|
EID: 0033027620
PISSN: 00257125
EISSN: None
Source Type: Journal
DOI: 10.1016/S0025-7125(05)70111-5 Document Type: Article |
|
Times cited : (10)
|
|
References (111)
|
